This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Government and industry leaders increasingly agree that governance is now foundational to AI — not optional — because…

This interview analysis is sponsored by AnswerRocket and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Enterprise organizations face decision-making pressures that are strikingly consistent across industries. As product portfolios expand, markets fragment, and…

Clinical trials comprise the most significant portion of drug development costs. In some cases, drug R&D costs can approach as high as $2 billion per drug and are accompanied by protracted timelines of 10-15 years. Pharmaceutical companies are turning to AI to shorten discovery timelines while dramatically upholding rigorous standards.​ AI-driven approaches have demonstrated meaningful…

SMBs are overwhelmed by multi-step operational work that drains time and headcount. Global trade processes remain slow, fragmented, and opaque. For all the focus on large enterprises in AI adoption, World Trade Organization working group documentation notes that SMBs make up nearly 90–95% of all global businesses and account for 60% of worldwide employment. Other…

This interview analysis is sponsored by Moody’s and was written, edited, and published in alignment with ourEmerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. High-stakes enterprise decisions are growing too complex for traditional automation to handle as fragmented data and regulatory pressures overwhelm…

​Edward Jones is a U.S.-based financial services firm focused on individual investors and small businesses. The company reported $16 billion in revenue for 2024, with fees contributing nearly $13.2 billion, and net income reached to $1.98 billion. The firm ranked No. 260 on the Fortune 500, based on its $16.3 billion in revenue. It has…

Modern vehicles are increasingly equipped with advanced technologies, including AI-powered sensors, image-based diagnostics, and automated damage detection, which enable faster and more accurate claims assessments. Recent research from Helwan University, Cairo, presents an academic Cost Estimation System that combines computer vision models with structured customer data to assess vehicle damage severity and estimate repair costs,…

This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. The current increase in capital allocation to GenAI — enterprise AI assistants and collaboration platforms like ChatGPT Enterprise…

This article is sponsored by Moody’s and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Regulated industries face compounding operational and regulatory pressures that steadily erode speed, accuracy, and competitiveness. Analysts lose hours to manual…

Samsung is a leading technology enterprise committed to helping people live more connected lives through innovative consumer electronics. The company has grown into a global powerhouse with a diverse range of businesses, including electronics, finance, chemicals, and more. In 2024, Samsung reported an annual revenue of $205 billion. Samsung also employed 262,647 people globally as…

Generative AI has been accelerating transformation across the life sciences, leaving pharmaceutical companies and clinical research organizations facing a dual challenge: modernizing pharmacovigilance while maintaining uncompromising standards for patient safety, data integrity, and global regulatory compliance. This delicate balance is most critical in adverse event detection and signaling, where a single missed risk can trigger…

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. In R&D-intensive sectors such as life sciences, agriculture, and advanced materials, a familiar challenge persists: fragmented data ecosystems,…